Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

35

Revenue 2017

Symbicort

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Symbicort was produced by AstraZeneca and Astellas.

AstraZeneca escapes pandemic impact as new drugs bolster revenues

AstraZeneca escapes pandemic impact as new drugs bolster revenues

Sales in AZ’s respiratory franchise were also better-than-expected, with sales of asthma treatment Symbicort (budesonide and formoterol fumarate dihydrate) increasing by 12% to bring in $653m – around $90m

GSK forges ahead with its dynamic COPD and asthma portfolio

GSK forges ahead with its dynamic COPD and asthma portfolio For instance, in the UK, US, Canada and Spain, the first treatment was an ICS/LABA, such Seretide or Symbicort, while in Germany it was a bronchodilator.

New hires at Crescendo, Healx and Galecto

New hires at Crescendo, Healx and Galecto In that role, he led the development of Symbicort, a leading respiratory brand.

AZ reports growth again in Q3, driven by oncology and China sales

AZ reports growth again in Q3, driven by oncology and China sales AZ’s respiratory franchise also grew 18% to $1.3bn – although the company saw a 4% decline in sales of Symbicort, this was offset by the growth of Pulmicort and Fasenra,

AZ builds case for its COPD triple as it chases GSK’s Trelegy

AZ builds case for its COPD triple as it chases GSK’s Trelegy reduction versus older drug Symbicort (formoterol fumarate/budesonide).

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...